Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?
Vertex Pharmaceuticals Ownership Summary
Vertex Pharmaceuticals is owned by 82.46% institutional investors, 0.21% insiders, and 17.34% retail investors. Capital world investors is the largest institutional shareholder, holding 9.92% of VRTX shares. Capital Group Growth Fnd of Amer Comp is the top mutual fund, with 5.48% of its assets in Vertex Pharmaceuticals shares.
VRTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vertex Pharmaceuticals | 82.46% | 0.21% | 17.34% |
| Sector | Healthcare Stocks | 35.71% | 11.88% | 52.41% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Capital world investors | 25.37M | 9.92% | $11.33B |
| Vanguard group | 24.11M | 9.43% | $10.93B |
| Blackrock funding, inc. /de | 23.97M | 9.37% | $10.70B |
| Capital research global investors | 21.13M | 8.26% | $9.43B |
| Blackrock | 21.31M | 8.25% | $9.99B |
| State street | 11.73M | 4.59% | $5.24B |
| Jpmorgan chase | 7.03M | 2.75% | $3.12B |
| Geode capital management | 6.14M | 2.40% | $2.73B |
| Capital investors | 5.13M | 2.00% | $2.29B |
| Loomis sayles & co l p | 4.00M | 1.57% | $1.79B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 330.00K | 11.93% | $154.68M |
| Bellevue group | 681.91K | 7.25% | $304.50M |
| Provident investment management | 147.62K | 6.55% | $65.92M |
| Andrew hill investment advisors | 11.96K | 4.76% | $5.34M |
| Montchanin asset management | 10.74K | 4.76% | $5.03M |
| Bridger management | 18.78K | 3.96% | $7.35M |
| Healthinvest partners ab | 22.98K | 3.61% | $11.17M |
| Superstring capital management lp | 11.01K | 3.51% | $4.92M |
| Artia global partners lp | 55.10K | 3.42% | $21.58M |
| Sivik global healthcare | 10.00K | 3.39% | $4.46M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital research global investors | 21.13M | 1.46% | 3.81M |
| Norges bank | 3.18M | 0.15% | 3.18M |
| Vanguard fiduciary trust | 1.47M | 0.17% | 1.47M |
| Jpmorgan chase | 7.03M | 0.20% | 993.67K |
| Goldman sachs group | 2.42M | 0.12% | 663.76K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Parnassus investments | - | - | -1.65M |
| Victory capital management | 1.89M | 0.54% | -1.47M |
| Winslow capital management | - | - | -887.64K |
| Artisan partners limited partnership | - | - | -650.26K |
| Blackrock | 21.31M | 0.23% | -648.44K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 3.18M | 0.15% | 3.18M | $1.44B |
| Vanguard fiduciary trust | 1.47M | 0.17% | 1.47M | $654.50M |
| Vanguard global advisers | 555.73K | 0.13% | 555.73K | $248.16M |
| Vanguard asset management | 442.18K | 0.17% | 442.18K | $197.45M |
| Lord, abbett | 166.51K | 0.24% | 166.51K | $74.35M |
Sold Out
| Holder | Change |
|---|---|
| Mcclarren financial advisors | -1.00 |
| Mine & arao wealth creation & management, llc. | -1.00 |
| Ruedi wealth management | -1.00 |
| Strategic advocates | -1.00 |
| Cgc financial services | -1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 1,587 | -7.84% | 210,840,715 | -10.55% | 82 | 0.97% | 765 | -12.97% | 538 | -6.43% |
| Dec 31, 2025 | 806 | -48.63% | 44,328,589 | -80.90% | 17 | 0.21% | 410 | -40.58% | 269 | -56.19% |
| Sep 30, 2025 | 865 | -46.24% | 59,581,660 | -75.23% | 23 | 0.26% | 362 | -50.82% | 356 | -41.54% |
| Jun 30, 2025 | 1,575 | -5.06% | 240,147,012 | 1.70% | 93 | 1.11% | 716 | -14.86% | 599 | 4.90% |
| Mar 31, 2025 | 1,640 | 1.74% | 235,693,425 | -0.06% | 91 | 1.09% | 829 | 11.42% | 567 | -7.35% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Capital Group Growth Fnd of Amer Comp | 13.93M | 5.48% | 950.21K |
| American Funds Growth Fund of Amer A | 13.93M | 5.48% | 950.21K |
| Vanguard Total Stock Mkt Idx Inv | 8.09M | 3.19% | 22.58K |
| Vanguard US Total Market Shares ETF | 8.18M | 3.19% | 16.09K |
| Vanguard Institutional 500 Index Trust | 7.30M | 2.84% | 51.91K |
| Vanguard 500 Index Investor | 6.59M | 2.60% | 118.31K |
| Capital Group Investment Co of Amer Comp | 6.27M | 2.46% | 832.14K |
| American Funds Invmt Co of Amer A | 6.27M | 2.46% | 832.14K |
| American Funds American Balanced A | 5.93M | 2.33% | 1.31M |
| Invesco QQQ Trust | 5.44M | 2.14% | 39.96K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Bozic Carmen | EVP and CMO | Sell | $471.41K |
| Jun 15, 2026 | Bozic Carmen | EVP and CMO | Sell | $1.83M |
| Jun 05, 2026 | Bozic Carmen | EVP and CMO | Sell | $785.25K |
| May 29, 2026 | Bozic Carmen | EVP and CMO | Sell | $888.30K |
| May 15, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $14.96K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 9 |
| 2026 Q1 | - | 56 |
| 2025 Q4 | - | 23 |
| 2025 Q3 | 4 | 1 |
| 2025 Q2 | - | 2 |
VRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools